Fan Zou

1.8k total citations · 1 hit paper
33 papers, 653 citations indexed

About

Fan Zou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Fan Zou has authored 33 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Fan Zou's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers) and Epigenetics and DNA Methylation (4 papers). Fan Zou is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (5 papers) and Epigenetics and DNA Methylation (4 papers). Fan Zou collaborates with scholars based in China, United States and Canada. Fan Zou's co-authors include Bingfeng Liu, Hui Zhang, Lijuan Lu, Jizhou Tan, Ting Liu, Jiaping Li, Yiwen Zhang, Linghua Li, Ya‐Ping Tang and Baijin Xia and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Journal of Virology.

In The Last Decade

Fan Zou

33 papers receiving 646 citations

Hit Papers

TREM2+ macrophages suppress CD8+ T-cell infiltration afte... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fan Zou China 13 314 257 248 69 68 33 653
Nam-Chul Jung South Korea 13 195 0.6× 336 1.3× 209 0.8× 56 0.8× 26 0.4× 18 609
Etsuko Fujii United States 15 185 0.6× 163 0.6× 141 0.6× 51 0.7× 41 0.6× 50 643
С. В. Сенников Russia 17 269 0.9× 556 2.2× 283 1.1× 32 0.5× 84 1.2× 143 931
Shajedul Islam Japan 7 367 1.2× 309 1.2× 219 0.9× 67 1.0× 22 0.3× 15 783
Tristan Courau France 11 382 1.2× 474 1.8× 205 0.8× 131 1.9× 24 0.4× 14 813
Álvaro de Mingo Pulido United States 10 495 1.6× 736 2.9× 363 1.5× 74 1.1× 38 0.6× 17 1.1k
Daria Briukhovetska Germany 6 273 0.9× 366 1.4× 202 0.8× 56 0.8× 37 0.5× 6 674
Changzheng Li China 12 162 0.5× 167 0.6× 177 0.7× 57 0.8× 20 0.3× 21 554
Won Jong Jin United States 14 286 0.9× 215 0.8× 228 0.9× 32 0.5× 28 0.4× 27 583
Bhalchandra Mirlekar United States 11 458 1.5× 643 2.5× 278 1.1× 60 0.9× 51 0.8× 15 973

Countries citing papers authored by Fan Zou

Since Specialization
Citations

This map shows the geographic impact of Fan Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fan Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fan Zou more than expected).

Fields of papers citing papers by Fan Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fan Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fan Zou. The network helps show where Fan Zou may publish in the future.

Co-authorship network of co-authors of Fan Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Fan Zou. A scholar is included among the top collaborators of Fan Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fan Zou. Fan Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linzhi, Pengcheng Jiang, Fan Zou, et al.. (2024). AURKB promotes bladder cancer progression by deregulating the p53 DNA damage response pathway via MAD2L2. Journal of Translational Medicine. 22(1). 295–295. 16 indexed citations
2.
Zou, Fan, Jialiang Wei, Jialang Zhuang, et al.. (2024). Moderate expression of CD39 in GPC3-CAR-T cells shows high efficacy against hepatocellular carcinoma. Frontiers of Medicine. 18(4). 708–720. 4 indexed citations
3.
Zou, Fan, et al.. (2024). Association between outdoor air pollutants and risk of acute exacerbation of chronic obstructive pulmonary disease in Xi’an, China. Air Quality Atmosphere & Health. 17(7). 1373–1390. 2 indexed citations
4.
Zhan, Haibo, Jun Xiao, Fan Zou, et al.. (2024). Pluripotent stem cell-derived CTLs targeting FGFR3-TACC3 fusion gene in osteosarcoma. International Immunopharmacology. 142(Pt B). 112862–112862. 1 indexed citations
5.
Xie, De, et al.. (2024). From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis. Frontiers in Pharmacology. 15. 1329409–1329409. 6 indexed citations
6.
Wang, Zefeng, et al.. (2024). EXO1/P53/SREBP1 axis-regulated lipid metabolism promotes prostate cancer progression. Journal of Translational Medicine. 22(1). 104–104. 12 indexed citations
7.
Zou, Fan, Rongli Wang, Lijun Wang, et al.. (2023). Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy. World Journal of Surgical Oncology. 21(1). 309–309. 7 indexed citations
8.
Qiao, Yidan, Jie Chen, Xuemei Wang, et al.. (2023). Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins. Cancer Communications. 43(7). 788–807. 36 indexed citations
9.
Xia, Baijin, Keming Lin, Xuemei Wang, et al.. (2023). Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment. Molecular Therapy — Oncolytics. 30. 86–102. 18 indexed citations
10.
Tan, Jizhou, Wenzhe Fan, Ting Liu, et al.. (2023). TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma. Journal of Hepatology. 79(1). 126–140. 121 indexed citations breakdown →
11.
Du, Manyu, et al.. (2022). Chemically Induced Chromosomal Interaction (CICI) method to study chromosome dynamics and its biological roles. Nature Communications. 13(1). 757–757. 3 indexed citations
12.
Zhang, Yiwen, Yingshi Chen, Rong Ma, et al.. (2020). UHRF1 Controls Thymocyte Fate Decisions through the Epigenetic Regulation of EGR1 Expression. The Journal of Immunology. 204(12). 3248–3261. 9 indexed citations
13.
Li, Xudong, Fan Zou, Yuanyuan Wu, et al.. (2020). Notch1 contributes to TNF-α-induced proliferation and migration of airway smooth muscle cells through regulation of the Hes1/PTEN axis. International Immunopharmacology. 88. 106911–106911. 22 indexed citations
14.
Zou, Fan, Lijuan Lu, Jun Liu, et al.. (2019). Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nature Communications. 10(1). 4109–4109. 92 indexed citations
15.
Zou, Fan & Lu Bai. (2018). Using time-lapse fluorescence microscopy to study gene regulation. Methods. 159-160. 138–145. 10 indexed citations
17.
Zou, Fan, et al.. (2015). A giant neurothekeoma of the left shoulder blade: A case report. Oncology Letters. 11(2). 1130–1134. 1 indexed citations
18.
Li, Wei, Fan Zou, Min Dai, Bin Zhang, & Tao Nie. (2015). A rare case of pure primary hemangioma of the scapula: A case report. Oncology Letters. 10(4). 2265–2268. 2 indexed citations
19.
Yu, Xiaolong, Xin Zhou, Changlin Fu, et al.. (2015). Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway. Oncology Reports. 34(3). 1129–1136. 42 indexed citations
20.
Yu, Xiaolong, Wei Li, Min Dai, et al.. (2015). Giant extra-articular synovial osteochondromatosis of the left proximal thigh: A case report. Oncology Letters. 10(6). 3577–3580. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026